Upon tumor-induced activation, they serve as major transporters of VEGF (159), which triggers the release of von Willebrand factor (vWF) and subsequent secretion of PDGF, TGF-β, and angiopoietin-1 (ANGPT-1). The gene discussed is VWF; the disease is neoplasm.